comparemela.com

Latest Breaking News On - Diagnostics stock down - Page 2 : comparemela.com

Cantor Fitzgerald Equities Analysts Reduce Earnings Estimates for Lucid Diagnostics Inc. (NASDAQ:LUCD)

Lucid Diagnostics Inc. (NASDAQ:LUCD – Free Report) – Investment analysts at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for shares of Lucid Diagnostics in a report issued on Wednesday, May 15th. Cantor Fitzgerald analyst R. Osborn now expects that the company will earn ($1.06) per share for the year, down from their […]

United-states
Nasdaq
Lucid-diagnostics-inc
Needham-company
Cantor-fitzgerald
Lucid-diagnostics
Free-report
Lucid-diagnostic
Get-free-report
Diagnostics-stock-down
Diagnostics-inc

Needham & Company LLC Reaffirms "Buy" Rating for Lucid Diagnostics (NASDAQ:LUCD)

Needham & Company LLC reaffirmed their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $2.50 price objective on the stock. Separately, Cantor Fitzgerald reduced their price target on shares of Lucid Diagnostics from $3.80 to $3.00 […]

United-states
Lucid-diagnostics-inc
Cantor-fitzgerald
Needham-company
Lucid-diagnostics
Free-report
Diagnostics-stock-down
Get-free-report
Diagnostics-inc
Esoguard-esophageal
Esocheck-esophageal-cell

Lucid Diagnostics (NASDAQ:LUCD) Earns Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Lucid Diagnostics (NASDAQ:LUCD – Free Report) in a research report report published on Monday, Benzinga reports. Needham & Company LLC currently has a $2.50 price objective on the stock. Separately, Cantor Fitzgerald lowered their target price on shares of Lucid Diagnostics from $3.80 to […]

United-states
Lucid-diagnostics-company-profile
Lucid-diagnostics-inc
Cantor-fitzgerald
Needham-company
Lucid-diagnostics
Free-report
Diagnostics-stock-down
Get-free-report
Diagnostics-inc
Esoguard-esophageal

Quest Diagnostics (NYSE:DGX) Rating Lowered to Hold at StockNews.com

StockNews.com cut shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a research report released on Friday morning. DGX has been the subject of a number of other research reports. Barclays lifted their price target on shares of Quest Diagnostics from $138.00 to $144.00 and gave the […]

United-states
Wellington
New-zealand-general
New-zealand
American
Catherinet-doherty
Michaele-prevoznik
Barclays
Citigroup
Wellington-management-group
Jpmorgan-chase-co

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Increase in Short Interest

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Sees Significant Increase in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Securities-exchange-commission
Cardio-diagnostics-company-profile
Cardio-diagnostics-holdings-inc
Vontobel-holding-ltd
Cardio-diagnostics-holdings
Get-free-report
Diagnostics-stock-down
Cardio-diagnostics
Free-report
Diagnostics-holdings
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.